Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Chinese state media seek to reassure public over COVID-19

Published 01/01/2023, 03:03 AM
Updated 01/01/2023, 02:50 PM
© Reuters. FILE PHOTO: Police guard an area to avoid mass gatherings during New Year's Eve celebration, amid the coronavirus disease (COVID-19) outbreak, in Wuhan, Hubei province, China December 31, 2022. REUTERS/Tingshu Wang/File Photo

By Martin Quin Pollard, Xiaoyu Yin and Tingshu Wang

WUHAN (Reuters) -Thousands of Chinese took to the streets to mark the New Year as authorities and state media sought to reassure the public that the COVID-19 outbreak sweeping across the country was under control and nearing its peak.

Though many people in major cities have continued to isolate as the virus spreads through the population, New Year revelries appeared to be mostly unaffected as people celebrated the end of 2022 and the turn into 2023.

In Wuhan, where the coronavirus was first identified at the end of 2019, residents said anxieties about the impact of easing strict zero-COVID restrictions to live with the disease had now abated - at least for the young and healthy.

"Basically, now my friends and I feel relatively positive and optimistic," said a 29-year old tutor surnamed Wu. "Many people are going out and about."

"We all know that especially for the middle-aged and the elderly, especially those over 60 years old, especially those with underlying diseases, they will be affected by this virus," he said.

A long line of people queued at the emergency department of Wuhan's Tongji Hospital, a major facility for COVID-19 patients, such as 72-year-old resident Huang, who wanted to be identified by her surname only.

"I don't feel well. I have no energy. I can't breathe. I used to be in good health. I had X-rays to check my lungs… This hospital is a lot of trouble, you have to wait a long time," she said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

DATA UNDER SCRUTINY

China's abrupt U-turn on COVID controls - as well as the accuracy of its case and mortality data - have come under increasing scrutiny both at home and overseas.

The surge in cases has raised fresh worries about the health of the economy and in his first public comments since the change in policy, President Xi Jinping called in a New Year's address for more effort and unity as China enters a "new phase".

China reported one new COVID-19 death in the mainland for Dec. 31, the same as a day earlier, the Chinese Center for Disease Control and Prevention said on Sunday.

The accumulated official death toll in China now stands at 5,249, far lower than in other large countries. The government has rejected claims that it has deliberately underreported the total number of fatalities.

At the Hankou funeral home on the outskirts of Wuhan, an intermittent stream of mourners and hearse drivers were arriving on Sunday.

Staff at the site's heavily guarded entrance declined to answer questions about their recent workloads. But funeral homes in other cities in China - including Chengdu and Beijing - said that they were busier than ever since China abruptly ditched its COVID curbs last month.

China's CDC reported 5,138 official confirmed cases on Saturday, but with mass testing no longer in operation, experts say the actual number of infections is significantly higher.

State media in the city of Guangzhou in southeastern China said on Sunday that daily cases peaked at around 60,000 recently, and now stand at around 19,000.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Authorities have been trying to reassure the public that they have the situation under control and state news agency Xinhua published an editorial on Sunday saying that the current strategy was "a planned, science-based approach" reflecting the changing nature of the virus.

REASSURANCE

Xinhua said separately the manufacturing of medicines had accelerated in the last month, with production of pain relievers ibuprofen and paracetamol now at 190 million tablets per day, five times higher than in early December.

Antigen test kit production has nearly doubled to 110 million per day in a month, it said.

On Sunday, Australia and Canada joined the United States and others in requiring travellers from China to provide negative COVID-19 tests when they arrive. Morocco will impose a ban on people arriving from China, its foreign ministry said.

Australian Health Minister Mark Butler said additional measures would also be considered amid concerns that China is not disclosing enough information about the nature and extent of the current outbreak.

Taiwan President Tsai Ing-wen offered on Sunday to provide China with "necessary assistance" to help it deal with the surge in COVID-19 cases.

Latest comments

china lies! only one death on dec31? liars! they lie to their people! is that where Republicans get all the lying , from communist dictators? traitors?
Keep your people living in fear China, it is the best tool of propaganda. Or just censor the truth as usual.
Hello Chinese people we get sick because we eat azz ok so stop eating azz it simple eating azz bad so don’t eat the azz no more
You can’t control this let people get sick commonist dummieeee
a realist bo ,they have a vaccine that is to no help and they wont listen to anybody
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.